MetLife Investment Management’s Core Molding Technologies CMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Hold
4,772
– – ﹤0.01% 2732
2026
Q1
$107K Buy
4,772
+1,693
+55% +$33.3K ﹤0.01% 2507
2025
Q4
$61.7K Sell
3,079
-2,264
-42% -$43.3K ﹤0.01% 2710
2025
Q3
$110K Hold
5,343
– – ﹤0.01% 2614
2025
Q2
$88.6K Buy
+5,343
New +$84K ﹤0.01% 2610
2024
Q4
– Sell
-4,460
Closed -$76.8K – 2822
2024
Q3
$76.8K Buy
4,460
+2,529
+131% +$44.1K ﹤0.01% 2704
2024
Q2
$30.8K Sell
1,931
-2,199
-53% -$40.2K ﹤0.01% 2848
2024
Q1
$78.2K Hold
4,130
– – ﹤0.01% 2643
2023
Q4
$76.5K Hold
4,130
– – ﹤0.01% 2709
2023
Q3
$118K Hold
4,130
– – ﹤0.01% 2497
2023
Q2
$94K Buy
+4,130
New +$80.2K ﹤0.01% 2716

Other funds holding CMT

MetLife Investment Management's CMT Position: Q2 2026 in Review

MetLife Investment Management held its Core Molding Technologies (CMT) position steady in Q2 2026 at 4,772 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

MetLife Investment Management first reported a position in CMT in Q2 2023 and has held it in 11 quarters since. The position peaked at $118K in Q3 2023. 90 funds tracked by Wall St. Rank hold CMT as of Q2 2026.

  • MetLife Investment Management held 4,772 shares of Core Molding Technologies worth $113K as of Q2 2026.
  • MetLife Investment Management left its Core Molding Technologies share count unchanged in Q2 2026.
  • Core Molding Technologies made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2732 holding.
  • MetLife Investment Management first reported a position in Core Molding Technologies in Q2 2023 and has held it in 11 quarters since.
  • MetLife Investment Management's Core Molding Technologies position peaked at $118K in Q3 2023.
  • 90 funds tracked by Wall St. Rank held Core Molding Technologies as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.